US Patent 11298362 Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer
Patent 11298362 was granted and assigned to Eli Lilly and Company on April, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 5, 2017
Date of Patent
April 12, 2022
Patent Applicant
Patent Application Number
16093123
Patent Citations Received
Patent Inventor Names
Bharvin Kumar Patel
0
Richard Paul Beckmann
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11298362 Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.